Stock Events

Stock Events

ENvue Medical

€0

0

+€0+0% Today

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

25FebExpected

Q4 0

Q3 2020

Q2 2025

Q3 2025

Q4 2025

-185.5

-185.17

-184.84

-184.5

Expected EPS

N/A

Actual EPS

N/A

Financials

-145.15%Profit Margin

Unprofitable

2019

2020

2021

2022

2023

2024

4.85MRevenue

-7.04MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 56R1.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Boston Scientific

Boston Scientific Corporation competes with NanoVibronix in the medical devices sector, focusing on products for various conditions that can overlap with NanoVibronix's pain management and wound healing solutions.

Medtronic plc offers a wide range of medical devices that compete directly with NanoVibronix's offerings, especially in the areas of pain management and therapeutic ultrasound technologies.

Johnson & Johnson

Johnson & Johnson, through its medical devices segment, competes in the same space as NanoVibronix, offering products that can be used in wound care, surgery, and pain management.

Stryker Corporation is a competitor due to its development and marketing of medical devices, including surgical equipment and orthopaedic devices that can be used in applications similar to NanoVibronix's.

Zimmer Biomet Holdings, Inc. competes with NanoVibronix in the orthopaedic market, particularly in products related to bone healing, which may overlap with NanoVibronix's therapeutic ultrasound technology.

Abbott Laboratories

Abbott Laboratories offers medical devices across various segments, including cardiovascular and neuromodulation, competing with NanoVibronix's pain management solutions.

Intuitive Surgical

Intuitive Surgical, Inc. competes by offering robotic-assisted surgical systems, which can be used in minimally invasive surgeries, a field where NanoVibronix's pain management and healing solutions could be applied.

Edwards Lifesciences

Edwards Lifesciences Corporation is a competitor in the field of patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring, areas where NanoVibronix's technologies could be beneficial.

Hologic, Inc. competes with NanoVibronix in the women's health market, offering diagnostic products, medical imaging systems, and surgical products that could be used alongside or in competition with NanoVibronix's solutions.

About

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

Show more...

CEO

ISIN

US63008J8844

WKN

000A41DDH

Listings

0 Comments

Share your thoughts

FAQ

What is ENvue Medical stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange ENvue Medical stocks are traded under the ticker 56R1.F.

Is ENvue Medical stock price growing?▼

56R1.F stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year ENvue Medical has showed a -89.7% decrease.

What is ENvue Medical revenue for the last year?▼

ENvue Medical revenue for the last year amounts to 4.85M EUR.

What is ENvue Medical net income for the last year?▼

56R1.F net income for the last year is -7.04M EUR.

In which sector is ENvue Medical located?▼

ENvue Medical operates in the Other sector.

When did ENvue Medical complete a stock split?▼

The last stock split for ENvue Medical was on August 12, 2025 with a ratio of 1:10.